TheraRadar
← Back
Data updated: Mar 29, 2026

MPP PHARMA

CardiovascularGastroenterologyImmunology
Generics

MPP PHARMA is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Immunology.

1959
Since
20
Drugs
-
Trials
313
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 29%
2 drugs
Gastroenterology 29%
2 drugs
Immunology 14%
1 drugs
Infectious Disease 14%
1 drugs
Respiratory 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology, Respiratory
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Gilead Sciences biotech
Infectious Disease, Immunology, Gastroenterology, Respiratory